119th Congress
H.R. 7902
Safeguarding Women from Chemical Abortion Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Diana Harshbarger(R-TN)
- Introduced
- Mar 12, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on the Judiciary
- Official text
- Introduced in House · Congress.gov page
Cosponsors (11)
Added later (11)
- John W. Rose (R-TN) · Mar 18, 2026
- Mark Alford (R-MO) · Mar 20, 2026
- Neal P. Dunn (R-FL) · Mar 20, 2026
- Sheri Biggs (R-SC) · Mar 24, 2026
- Tracey Mann (R-KS) · Mar 24, 2026
- Christopher H. Smith (R-NJ) · Apr 22, 2026
- Mary E. Miller (R-IL) · May 14, 2026
- W. Gregory Steube (R-FL) · May 21, 2026
- Ralph Norman (R-SC) · Aug 31, 2026
- Roger Williams (R-TX) · Aug 31, 2026
- Andrew S. Clyde (R-GA) · Sep 1, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Latest action(Mar 12, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 12, 2026 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Mar 12, 2026
Introduced in House